Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Inflammatory Bowel Diseases

Free Subscription 04.05.2025 5 Aliment Pharmacol Ther 2 Am J Gastroenterol 3 BMC Gastroenterol 6 Dig Dis Sci 1 Dis Colon Rectum 2 Gut 9 Inflamm Bowel Dis 3 J Crohns Colitis 1 J Gastroenterol 4 Scand J Gastroenterol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Aliment Pharmacol Ther

1. ANAND E, Tozer P
   Editorial: Seton Use in Perianal Fistulising Crohn's Disease.
   Aliment Pharmacol Ther. 2025 Apr 27. doi: 10.1111/apt.70094.
   PubMed        
   
   
2. FITZPATRICK JA, Gibson PR, Halmos EP
   Editorial: Inflammatory Bowel Disease and Dietary Emulsifiers-A Conundrum That Continues. Authors' Reply.
   Aliment Pharmacol Ther. 2025 Apr 29. doi: 10.1111/apt.70148.
   PubMed        
   
   
3. GOLD S, Haskey N, Raman M
   Editorial: Inflammatory Bowel Disease and Dietary Emulsifiers-A Conundrum That Continues.
   Aliment Pharmacol Ther. 2025 Apr 29. doi: 10.1111/apt.70112.
   PubMed        
   
   
4. EBRAHIMI R, Ebrahimi F, Niess JH, Mahdi A, et al
   Increased Risk of Cardiovascular Events After Coronary Interventions in Inflammatory Bowel Disease: A Nationwide Matched Cohort Study.
   Aliment Pharmacol Ther. 2025 Apr 29. doi: 10.1111/apt.70162.
   PubMed         Abstract available
   
   
5. MCCURDY JD, Macdonald B, Rosenfeld G, Bessissow T, et al
   Editorial: Seton Use in Perianal Fistulising Crohn's Disease. Authors' Reply.
   Aliment Pharmacol Ther. 2025 Apr 27. doi: 10.1111/apt.70170.
   PubMed        
   
   

   
   Am J Gastroenterol

6. CHESTER MA, Keefer L
   Beyond Depression and Anxiety in Inflammatory Bowel Diseases: Forging a Path Toward Emotional Healing.
   Am J Gastroenterol. 2025;120:999-1006.
   PubMed         Abstract available
   
   
7. KOCHHAR GS, Dziegielewski C, Schairer JN, Cross RK, et al
   Role of Endoscopy in Inflammatory Bowel Disease: What Every Gastroenterologist Should Know.
   Am J Gastroenterol. 2025 Apr 29. doi: 10.14309/ajg.0000000000003507.
   PubMed         Abstract available
   
   

   
   BMC Gastroenterol

8. ELAINEIN MAA, ElSherefy SS, Yousef NM, ElKady SM, et al
   Efficacy and safety of Mirikizumab for ulcerative colitis: a systematic review and meta-analysis of randomized controlled trials.
   BMC Gastroenterol. 2025;25:307.
   PubMed         Abstract available
   
   
9. ALOTAIBI AD, Al-Abdulwahab AA, Ismail MH, AlElyani JM, et al
   Prevalence of H. Pylori in inflammatory bowel disease patients and its association with severity.
   BMC Gastroenterol. 2025;25:317.
   PubMed         Abstract available
   
   
10. YAMADA Y, Ishida N, Takebe T, Takahashi K, et al
    Vedolizumab-steroid combination therapy improves long-term prognosis in patients with ulcerative colitis.
    BMC Gastroenterol. 2025;25:323.
    PubMed         Abstract available
    
    

    
    Dig Dis Sci

11. OWAIS M, Malani AK, Ameer F, Siddique A, et al
    Comments on "Evaluation of an Exercise Program in Patients with Inflammatory Bowel Disease: A Pilot Study".
    Dig Dis Sci. 2025 May 2. doi: 10.1007/s10620-025-09085.
    PubMed        
    
    
12. BAHIRWANI J, Elmer J, Eskarous H, Jai Kumar Ahuja S, et al
    Frailty Prevalence and Evaluation of the FRAIL Scale Questionnaire in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2025 Apr 29. doi: 10.1007/s10620-025-09073.
    PubMed         Abstract available
    
    
13. LIM Y, Park B, Jeon K, Jeong OS, et al
    Annual Therapeutic Drug Monitoring in Patients with Inflammatory Bowel Disease During Infliximab Maintenance Therapy: Balancing Efficacy with Risk of Pharmacokinetic Failure.
    Dig Dis Sci. 2025 Apr 29. doi: 10.1007/s10620-025-09032.
    PubMed         Abstract available
    
    
14. MAGEN-RIMON R, Cohen M, Rosen I, Spector-Cohen I, et al
    Adipokine Profiles and Their Association with Body Composition and Disease Activity in Pediatric Crohn's Disease.
    Dig Dis Sci. 2025 Apr 29. doi: 10.1007/s10620-025-08941.
    PubMed         Abstract available
    
    
15. ZHANG D, Sun Y, Wang J
    Transanal Opening of the Intersphincteric Space (TROPIS): Combined with Suture-Dragging for Treating of Rectovaginal and Perianal Fistulas in Crohn's Disease with Anorectal Stricture.
    Dig Dis Sci. 2025 Apr 28. doi: 10.1007/s10620-025-09059.
    PubMed        
    
    
16. ZHENG W, Kiran RP, Shen B
    Endoscopic Therapy for Anastomotic Bleeding in Inflammatory Bowel Disease.
    Dig Dis Sci. 2025 Apr 25. doi: 10.1007/s10620-025-09029.
    PubMed         Abstract available
    
    

    
    Dis Colon Rectum

17. MORTREUX P, Leroyer A, Ley D, Dupont C, et al
    Natural History of Anal Strictures in Pediatric-Onset Crohn's Disease: Long-term Follow-up of a Population-Based Study.
    Dis Colon Rectum. 2025 Apr 29. doi: 10.1097/DCR.0000000000003788.
    PubMed         Abstract available
    
    

    
    Gut

18. TSCHURTSCHENTHALER M
    Dietary modulation of the gut phageome: a cross-kingdom dialogue in Crohn's disease.
    Gut. 2025 Apr 29:gutjnl-2025-335261. doi: 10.1136/gutjnl-2025-335261.
    PubMed        
    
    
19. EAST JE, Gordon M, Nigam GB, Sinopoulou V, et al
    British Society of Gastroenterology guidelines on colorectal surveillance in inflammatory bowel disease.
    Gut. 2025 Apr 30:gutjnl-2025-335023. doi: 10.1136/gutjnl-2025-335023.
    PubMed         Abstract available
    
    

    
    Inflamm Bowel Dis

20. KHALILI H, Forss A, Soderling J, Broms G, et al
    Statin Use is Associated with a Less Severe Disease Course In Inflammatory Bowel Disease: A Nationwide Cohort Study 2006-2020.
    Inflamm Bowel Dis. 2025 Apr 25:izaf077. doi: 10.1093.
    PubMed         Abstract available
    
    
21. HUET J, Mathieu K, Dodel M, Coban D, et al
    Transmural Healing Assessed by Combination of Fecal Calprotectin and Intestinal Ultrasonography Is Associated With Reduced Risk of Bowel Damage Progression in Patients With Crohn's Disease.
    Inflamm Bowel Dis. 2025 Apr 25:izaf068. doi: 10.1093.
    PubMed         Abstract available
    
    
22. HANSEN SH, Maseng MG, Granno O, Vestergaard MV, et al
    Fecal Microbiome Reflects Disease State and Prognosis in Inflammatory Bowel Disease in an Adult Population-Based Inception Cohort.
    Inflamm Bowel Dis. 2025 Apr 25:izaf060. doi: 10.1093.
    PubMed         Abstract available
    
    
23. RODRIGUEZ A, Quintero MA, Hazime H, Killian R, et al
    Risk Factors for Chronic Kidney Disease in Patients With Crohn's Disease.
    Inflamm Bowel Dis. 2025 Apr 25:izaf039. doi: 10.1093.
    PubMed         Abstract available
    
    
24. DAI C, Huang YH
    Extraintestinal Manifestations in Patients With Ulcerative Colitis Post-Restorative Proctocolectomy and Ileal Pouch-Anal Anastomosis.
    Inflamm Bowel Dis. 2025 Apr 26:izaf080. doi: 10.1093.
    PubMed        
    
    
25. REA K, Robbertz A, Westbrook A, Buzenski J, et al
    Biofeedback-Enhanced Cognitive-Behavioral Therapy Delivered Virtually to Youth With Inflammatory Bowel Disease: A Randomized Controlled Trial.
    Inflamm Bowel Dis. 2025 Apr 29:izaf061. doi: 10.1093.
    PubMed         Abstract available
    
    
26. PLAKOTARIS E, Theriot T, Langley C, Haas C, et al
    Diagnosing the Overlap: Metastatic Crohn's Disease With Hidradenitis Suppurativa-Like Features.
    Inflamm Bowel Dis. 2025 Apr 29:izaf083. doi: 10.1093.
    PubMed        
    
    
27. BARENBOIM A, Maharshak N
    Reply: Extraintestinal Manifestations in Patients With Ulcerative Colitis Post-Restorative Proctocolectomy and Ileal Pouch-Anal Anastomosis.
    Inflamm Bowel Dis. 2025 Apr 29:izaf091. doi: 10.1093.
    PubMed        
    
    
28. ERNEST-SUAREZ K, Noor NM
    Not All Transmural Healing is Equal in Crohn's Disease: Magnetic Resonance Enterography and Intestinal Ultrasound for Stricture Assessment in the STRIDENT Trial.
    Inflamm Bowel Dis. 2025 Apr 29:izaf093. doi: 10.1093.
    PubMed        
    
    

    
    J Crohns Colitis

29. DOLINGER MT, Aronskyy I, Spencer EA, Pittman N, et al
    Early Intestinal Ultrasound Response to Biologic and Small Molecule Therapy is Accurate to Predict Treat-To-Target Endoscopic Outcomes in Children with Ulcerative Colitis: Results from the Prospective Super Sonic-UC Study.
    J Crohns Colitis. 2025 May 2:jjaf075. doi: 10.1093.
    PubMed         Abstract available
    
    
30. LINGGI B, Salas A, Steere B, Verstockt B, et al
    Expert Recommendations to Standardise Transcriptomic Analysis in Inflammatory Bowel Disease Clinical Trials.
    J Crohns Colitis. 2025 Apr 29:jjaf068. doi: 10.1093.
    PubMed         Abstract available
    
    
31. JOHNSON AM, Askar M, Belani S, Khan A, et al
    A Multicenter Study of the Real-World Effectiveness and Safety of Risankizumab in Crohn's Disease.
    J Crohns Colitis. 2025 Apr 24:jjaf070. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Gastroenterol

32. JUN YK, Choi Y, Shin CM, Park YS, et al
    Impact of early aggressive treatment on long-term biochemical marker patterns in inflammatory bowel disease.
    J Gastroenterol. 2025 May 2. doi: 10.1007/s00535-025-02244.
    PubMed         Abstract available
    
    

    
    Scand J Gastroenterol

33. MAURUD S, Lunde L, Moen A, Opheim R, et al
    Mapping conditional health literacy and digital health literacy in patients with inflammatory bowel disease to optimise availability of digital health information: a cross-sectional study.
    Scand J Gastroenterol. 2025 May 2:1-12. doi: 10.1080/00365521.2025.2497952.
    PubMed         Abstract available
    
    
34. TUKEK NB, Bakkaloglu OK, Sen G, Hatemi I, et al
    The effects of biologics on ulcerative colitis-related colectomy rate: results of a 22-year study.
    Scand J Gastroenterol. 2025 Apr 29:1-10. doi: 10.1080/00365521.2025.2497954.
    PubMed         Abstract available
    
    
35. BROMS G, Forss A, Eriksson J, Askling J, et al
    Adult-onset inflammatory bowel disease and the risk of venous thromboembolism - a Swedish nationwide cohort study 2007-2021.
    Scand J Gastroenterol. 2025 Apr 26:1-10. doi: 10.1080/00365521.2025.2488053.
    PubMed         Abstract available
    
    
36. TIANEZE DE CASTRO C, da Silva Oliveira D, Freire de Melo F, Lima Barreto M, et al
    Global prevalence of biologic drugs use in inflammatory bowel diseases: a systematic review and meta-analysis.
    Scand J Gastroenterol. 2025;60:439-453.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge.